Oncology - Medical Oncology Physician
Company: Curative
Location: New Orleans
Posted on: October 22, 2024
Job Description:
Opportunity Overview: We are searching for a Gastroenterology
Oncologist to join our department in New Orleans. We are an
emerging NCI-designated comprehensive cancer center whose purposes
are the treatment and control of cancer, the advancement of
biomedical knowledge through laboratory and clinical research, and
the training of physicians, scientists, and other healthcare
workers. Our institution is among an elite group of 71 research
universities, and we empower our physicians to become leaders in
their field by collaborating with bench researchers, heading
clinical trials, and publishing as primary authors for
translational clinical trial research. About the Role:
- You will be responsible for teaching fellows, residents, and
medical students in addition to leading clinical trial
research.
- 50% protected time (minimum), allowing for dedicated focus on
academic pursuits.
- You will collaborate with a dedicated team of 3 Hepatologists
and specialized Gastroenterology faculty.
- Receive strong APP support for clinical care. Research
Opportunities and Clinical Trials: We have a variety of clinical
trials that directly contribute to advancing treatment options for
this specific cancer population. You will be at the forefront of
new immunotherapy and chemotherapy regimens while collaborating
with a team focused on improving patient outcomes and pioneering
leading-edge research. Trial 1: MSI-H/dMMR Gastric or GEJ Cancer
- This trial is for patients with a specific genetic mutation
(MSI-H/dMMR) in gastric or gastroesophageal junction cancer.
- It investigates a new immunotherapy drug, atezolizumab, for
controlling the spread of cancer.
- The trial will compare atezolizumab alone (monotherapy) and
combined with chemotherapy. Trial 2: Inoperable Colorectal Liver
Metastases
- This trial is for patients with inoperable cancer that has
spread to the liver from the colon or rectum.
- It compares a new approach using Hepatic Arterial Infusion
(HAI) pump chemotherapy alongside the standard treatment to the
standard treatment alone.
- HAI delivers high doses of chemotherapy directly to the liver
tumors, potentially improving tumor control and survival. Trial 3:
Resected Pancreatic Cancer with BRCA Mutation
- This Phase II clinical trial studies the effectiveness of
adding olaparib, a drug that blocks DNA repair, to the treatment
plan of patients with pancreatic cancer.
- The patients must have undergone surgery to remove the cancer
(resection).
- They must also have a specific genetic mutation (BRCA1, BRCA2,
or PALB2).
- The goal is to see if blocking DNA repair in cancer cells with
these mutations helps kill them. Location:
- This historic city also offers state-of-the-art medical
facilities, professional sports teams, and excellent major
university programs. JN -4
Keywords: Curative, Baton Rouge , Oncology - Medical Oncology Physician, Healthcare , New Orleans, Louisiana
Didn't find what you're looking for? Search again!
Loading more jobs...